House OKs drug safety bill

The House of Representatives passed a bill on Wednesday that backs new FDA authority over drug safety, including allowing the FDA to require new studies, order label changes and monitor drugs on the market. The bill also renews for five years two programs to collect user fees from drug and medical device manufacturers.

View Full Article in:

Google · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA